Healthcare: Pharmaceutical market in Romania grew by 11% last year, to 12.95 billion lei
The pharmaceutical market in Romania recorded last year a 10.6% increase, to 12.95 billion lei (2.9 billion euros), according to a report published by Antibiotice Iasi, the most important Romanian producer of generic medicines.
In 2015, the value of the pharmaceutical market in Romania was 11.7 billion lei (2.6 billion euros). The positive evolution was backed by the increased consumption of medicines by 471 million units, from 11.2 billion units in 2015 to 11.27 billions in 2016.
With a sale value of 300 million lei, Antibiotice ranks 4th among producers of generic medicines with medical prescription and medicines those without medical prescription. The most important growth was recorded in top 10, the document mentions.
Medicine sales through retail drug stores climbed by 3.7% last year, compared to 2015, from 215.5 million lei to 223.6 million lei, while sales to hospitals went up by 6.5% to 76.5 million lei.
Antibiotice Iasi exports were about 25.6 million dollars in 2016, on the rise by 11.6% compared to 2015.
The largest export deliveries were to Asian states (40%), to North America (24%), while the rest was exported to Europe (19%), Russia and CIS (7%), South America (6%), Africa (3%) and Australia (1%).
Antibiotice Iasi has 140 generic medicines from 12 therapeutic areas in its portfolio.
The company recorded last year sales of 332.4 million lei, on the rise by 1% against 2015, and a net profit of 30.4 million lei, 12% higher.
The company is listed with Bucharest Stock Exchange (BVB), with a capitalization of 377.3 million lei (83.1 million euros). The Health Ministry is majority shareholder with 53.01% of shares.